{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:04:35Z","timestamp":1792706675554,"version":"4.5.0"},"reference-count":34,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,1,20]]},"abstract":"<jats:p>Linezolid standard dosing is fixed at 600\u2009mg every 12\u2009h (q12h) for adults. Literature suggests critically ill, obese patients require higher doses.<\/jats:p>","DOI":"10.1128\/aac.01619-20","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T14:04:33Z","timestamp":1606831473000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":37,"title":["Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue Infections"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1835-4515","authenticated-orcid":false,"given":"Alison L.","family":"Blackman","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Sciences, University of Maryland, Baltimore, Maryland, USA"},{"name":"R.A. Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praneeth","family":"Jarugula","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Sciences, University of Maryland, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-0165","authenticated-orcid":false,"given":"David P.","family":"Nicolau","sequence":"additional","affiliation":[{"name":"Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Ho","family":"Chui","sequence":"additional","affiliation":[{"name":"R.A. Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Joshi","sequence":"additional","affiliation":[{"name":"R.A. Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, Maryland, USA"},{"name":"Department of Medicine, University of Maryland, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Heil","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Sciences, University of Maryland, Baltimore, Maryland, USA"},{"name":"R.A. Cowley Shock Trauma Center, University of Maryland Medical Center, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathangi","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Sciences, University of Maryland, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0601-x"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161040-00008"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2260-2266.2005"},{"key":"e_1_3_1_5_2","volume-title":"Zyvox package insert","author":"Pharmacia & Upjohn","year":"2000","unstructured":"Pharmacia & Upjohn. 2000. Zyvox package insert. Pharmacia & Upjohn, LLC, New York, NY."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.8.1081"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328359a4c1"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.01.009"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000401"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000356"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky500"},{"key":"e_1_3_1_12_2","volume-title":"Pharmacokinetics of linezolid in obese hospitalized patients utilizing higher doses","author":"Cheatham SC","year":"2010","unstructured":"Cheatham SC, Kays MB, Fleming MR, Shawa I. 2010. Pharmacokinetics of linezolid in obese hospitalized patients utilizing higher doses. Poster, Boston, MA."},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01453-12"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0606-5"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13262"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01378-08"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01185-10"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.11.016"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21654"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2011.652164"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R707"},{"key":"e_1_3_1_22_2","first-page":"1418","article-title":"Linezolid use in ventilator-associated pneumonia: look at the body weight of your patient!","volume":"78","author":"De Pascale G","year":"2012","unstructured":"De Pascale G, Fortuna S, Navarra P, Antonelli M. 2012. Linezolid use in ventilator-associated pneumonia: look at the body weight of your patient! Minerva Anestesiol 78:1418\u20131419.","journal-title":"Minerva Anestesiol"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv238"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/62.5.464a"},{"key":"e_1_3_1_25_2","volume-title":"Evaluation of clinical outcomes and adverse events when administering alternative doses of linezolid to obese patients","author":"Fleming MR","year":"2011","unstructured":"Fleming MR, Cheatham SC, Kays MB. 2011. Evaluation of clinical outcomes and adverse events when administering alternative doses of linezolid to obese patients. Poster, Pittsburgh, PA."},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw248"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2835"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz374"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000431"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.5.605"},{"key":"e_1_3_1_31_2","volume-title":"Population pharmacokinetics: FDA guidance for industry","author":"Food and Drug Administration","year":"2010","unstructured":"Food and Drug Administration. 2010. Population pharmacokinetics: FDA guidance for industry. Food and Drug Administration, Silver Spring, MD."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj070353"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01885-13"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.46.8.2723-2726.2002"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16235"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01619-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01619-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:51:41Z","timestamp":1645480301000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01619-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,20]]}},"alternative-id":["10.1128\/AAC.01619-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01619-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"2020-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01619-20"}}